ANCHOR
Assessment of ECMO in acute myocardial infarction with Non-reversible, Cardiogenic shock to Halt Organ failure & Reduce mortality.
This study is a prospective, open-label, multicenter, randomized, controlled trial including patients with ongoing myocardial ischemia complicated by cardiogenic shock with the intention to undergo early revascularization. The study goal is to determine if early VA-ECMO insertion in conjunction with optimal medical treatment is superior to optimal medical treatment alone after early revascularization.